Author

Jiasheng Zong

Institutions: Shanghai Jiao Tong University, Renji Hospital

Observed institutions: Shanghai Jiao Tong University, Renji Hospital

OpenAlex ID: A5111139433

Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancer

2024 · Yanfei Shao, Galiya Yesseyeva, et al. · Genomics · 7

Abstract B024: Cisplatin primes an interferon-driven CD8+ central memory T cell program to enable oncolytic virotherapy in gastrointestinal cancer malignancies

2026 · Joseph Brandon. Parker, Zhongyi Dong, et al. · Clinical Cancer Research

Platinum chemotherapy and oncolytic virotherapy as used to cooperatively sustain stem-like CD8⁺ T-cell immunity via type I interferon modulation.

2026 · Vivienne Yang, Zhongyi Dong, et al. · Journal of Clinical Oncology

Unveiling the prognostic and therapeutic landscape of the zinc transporter protein SLC39A family in colorectal cancer through multi-omics and machine learning approaches

2026 · Haizhen Chen, Chaozhao Chen, et al. · Clinical and Experimental Medicine

The safety and efficacy of recombinant human adenovirus 5 injection (H101) intraperitoneal administration combined with tislelizumab and platinum, fluorouracil-based drugs in the treatment of gastric cancer with peritoneal metastasis: an open-label, single-arm, prospective clinical study protocol

2026 · Jiasheng Zong, Zhongyi Dong, et al. · Future Oncology

The safety and efficacy of recombinant human adenovirus 5 injection (H101) intraperitoneal administration combined with tislelizumab and platinum, fluorouracil-based drugs in the treatment of gastric cancer with peritoneal metastasis: an open-label, single-arm, prospective clinical study protocol

2026 · Jiasheng Zong, Zhongyi Dong, et al. · Figshare

Works count: 6

Citation count: 7

H-index: 1

I10-index: